Industry reports
Editor highlights

Publication dates

data types

Cancer Therapeutics Market and Forecasts, April 2014

You might be interested in: clinical trial, hearing loss, cancer, more »


 
1-10 of 37 reports for Cancer Therapeutics

U.S. Therapy Business

  • Industry report
  • February 2012
  • 26 pages

... Migrating to new distant sites and seeding new tumors. Vicrostatin, the company S lead cand, demonstrated strong anti-cancer therapeutic effects in six aggressive metastatic cancers through anti ...

Diagnostics Industry Brief

  • Industry report
  • June 2012
  • 19 pages
  • by Non Governmental Organization (NGO)

... Opportunity to share in the early-stage investment risk with the nci cancer therapeutics Small molecule anticancer agents Anticancer biologics, including therapeutic vaccines Multifunctional cancer ...

Therapy in Malaysia and Philippines : Innovation and Technology Trends

  • Industry report
  • February 2013
  • 2 pages

... Inhibitor (13nth001) 62 novel cancer therapeutic ape1 inhibitor (13nth001) business opportunity the global market for cancer therapies is worth $47.3 Billion in 2008. This should increase to over usd ...

Drug and Medication Sector in South Korea and The United States

  • Industry report
  • March 2012
  • 25 pages

... Molecular-targeted cancer therapeutic, cg200745 (in phase i) key projects cg100649: to form strategic alliance or co-development and initiate phase iii study cg400549: to complete phase iia study cg200745 ...

Diagnostics : Innovation and Technology Trends

  • Industry report
  • October 2012
  • 71 pages

... Substantial proof-of-concept data already exists head2rightopportunity to share in the early-stage investment risk with the nci cancer therapeutics (fy09) Small molecule anticancer agents Anticancer ...

Hospital : Innovation and Technology Trends

  • Industry report
  • January 2012
  • 12 pages

... therapeutics in 2012, we celebrated, in conjunction with mcmaster university, the recruitment of dr. Paola muti as the inaugural holder of the arcelormittal dofasco chair in experimental cancer ...

Pharmaceutical in The United States : Innovation and Technology Trends

  • Industry report
  • January 2012
  • 21 pages

... Assessment of the older patient Basic mechanisms of cancer therapeutics study section [bmct] Cancer biomarkers study section [cbss] Chemo/dietary prevention study section [cdp] Cancer immunopathology ...

Pharmaceutical in The United States : Innovation and Technology Trends

  • Industry report
  • November 2012
  • 29 pages

... For cancer Example: the nanotechnology characterization laboratory (ncl) provides preclinical efficacy and toxicity testing of nanotech cancer therapeutics and diagnostics. Early clinical trials program ...

Diagnostics in The United States : Innovation and Technology Trends

  • Industry report
  • October 2012
  • 15 pages

... Annual reports (phase ii) monthly or quarterly progress reports set-aside of funds for particular areas No yes 10 fy13 nci contract funding topics 11 313 Rnai cancer therapeutics using ...

Vaccine Market in China

  • Industry report
  • March 2013
  • 15 pages
  • by Intergovernmental Agency

... Of clinical trail and production patents certificate of state and province projects rabies scfv antibody pre-clinical apply for production approve to produce market cancer ...

» Purchase Premium Reports (From $ 125 - $ 26 010)

About 100 reports for Cancer Therapeutics
Bionomics Limited (Symbol:BNO) SWOT Analysis, Strategy, Revenues and Profits

Bionomics Limited (Symbol:BNO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.